News
DRTSW
0.9500
+1.06%
0.0100
Weekly Report: what happened at DRTS last week (0406-0410)?
Weekly Report · 3d ago
Weekly Report: what happened at DRTS last week (0330-0403)?
Weekly Report · 04/06 09:31
Alpha Tau Wins First DDW Oral Slot for Alpha DaRT Pancreatic Cancer Data
TipRanks · 03/31 21:21
ALPHA TAU ANNOUNCES FIRST-EVER ORAL PRESENTATION OF ALPHA DART® PANCREATIC CANCER DATA AT DIGESTIVE DISEASE WEEK (DDW) 2026
Reuters · 03/31 13:15
Weekly Report: what happened at DRTS last week (0323-0327)?
Weekly Report · 03/30 09:31
Alpha Tau Medical: 2026 Is The Breakthrough Year
Seeking Alpha · 03/24 04:31
Weekly Report: what happened at DRTS last week (0316-0320)?
Weekly Report · 03/23 09:30
Alpha Tau Medical Director Michael Avruch Files Initial Beneficial Ownership Statement
Reuters · 03/18 23:05
Alpha Tau Medical Ltd. files initial beneficial ownership statement for Director Nadav Kidron
Reuters · 03/18 23:04
Alpha Tau Medical CEO and Director Uzi Sofer files initial beneficial ownership statement
Reuters · 03/18 23:04
Alpha Tau Medical Director Alan Adler Files Initial Beneficial Ownership Statement
Reuters · 03/18 23:03
Alpha Tau Medical Director Samuel Morry Blumenfeld Files Initial Beneficial Ownership Statement
Reuters · 03/18 23:03
Alpha Tau Medical Ltd. Director David Mark Milch Files Initial Beneficial Ownership Statement
Reuters · 03/18 23:01
Alpha Tau Medical Ltd. Director Alon Ruth Files Initial Beneficial Ownership Statement
Reuters · 03/18 23:01
Alpha Tau Medical Ltd. Director Maya Netser Files Initial Beneficial Ownership Statement
Reuters · 03/18 23:00
Alpha Tau Medical Ltd. files Form 3 initial beneficial ownership statement for CFO Raphi Levy
Reuters · 03/18 22:59
Alpha Tau CFO Raphi Levy to present at Sidoti Virtual Small Cap Conference
Reuters · 03/16 14:02
Weekly Report: what happened at DRTS last week (0309-0313)?
Weekly Report · 03/16 09:29
Alpha Tau Medical Is Maintained at Buy by Citigroup
Dow Jones · 03/11 16:02
Alpha Tau Medical Price Target Raised to $9.00/Share From $7.00 by Citigroup
Dow Jones · 03/11 16:02
More
Webull provides a variety of real-time DRTSW stock news. You can receive the latest news about Alpha Tau Medical Ltd through multiple platforms. This information may help you make smarter investment decisions.
About DRTSW
Alpha Tau Medical Ltd is an Israel-based medical technology company that focuses on research, development and commercialization of Alpha DaRT Diffusing Alpha-emitters Radiation Therapy (Alpha DaRT) for the treatment of solid cancer. Company's technology relies on the diffusion of atoms that emit alpha particles within the tumor tissue, and enables alpha radiation to reach the the entire tumor. Precise amounts of radioactive radium-224 affixed that emit short-range alpha radiation enables to damages and kills cancer cells within a short period of time. The Company has one subsidiary Healthcare Capital Corp.